By John Eggerton, Broadcasting & Cable Online, 7-9-19

In a victory for drug companies and marketers, a federal district judge has vacated a Trump Administration rule that drug manufacturers have to disclose their list prices in direct-to-consumer (DTC) TV, radio, and online drug ads.

Drug companies had argued that the mandate would cause confusion, exceeded the Administration’s authority, and was unconstitutional.

In May, the Department of Health and Human Services (HHS) as part of the Administration’s effort to lower drug prices, said that drug companies had to “disclose the list price to patients for prescription drugs and biological products in their TV (broadcast, cable and satellite) and online ads.”  » Read More